{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T14:30:39Z","timestamp":1780410639586,"version":"3.54.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,1,24]],"date-time":"2021-01-24T00:00:00Z","timestamp":1611446400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,24]],"date-time":"2021-01-24T00:00:00Z","timestamp":1611446400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s10585-021-10074-2","type":"journal-article","created":{"date-parts":[[2021,1,24]],"date-time":"2021-01-24T08:02:51Z","timestamp":1611475371000},"page":"187-196","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The role of intraperitoneal chemotherapy in the surgical management of pancreatic ductal adenocarcinoma: a systematic review"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9607-6987","authenticated-orcid":false,"given":"Alexandre","family":"Brind\u2019Amour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Parapini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Sid\u00e9ris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Segedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen W.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Chartier-Plante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Dub\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles H.","family":"Scudamore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter T. W.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,24]]},"reference":[{"issue":"6","key":"10074_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394\u2013424","journal-title":"CA Cancer J Clin"},{"issue":"44","key":"10074_CR2","doi-asserted-by":"crossref","first-page":"9694","DOI":"10.3748\/wjg.v22.i44.9694","volume":"22","author":"M Ilic","year":"2016","unstructured":"Ilic M, Ilic I (2016) Epidemiology of pancreatic cancer. World J Gastroenterol 22(44):9694\u20139705","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10074_CR3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14740\/wjon1166","volume":"10","author":"P Rawla","year":"2019","unstructured":"Rawla P, Sunkara T, Gaduputi V (2019) Epidemiology of pancreatic cancer: global trends, etiology and risk factors. World J Oncol 10(1):10\u201327","journal-title":"World J Oncol"},{"issue":"8","key":"10074_CR4","first-page":"626","volume":"89","author":"MS De La Cruz","year":"2014","unstructured":"De La Cruz MS, Young AP, Ruffin MT (2014) Diagnosis and management of pancreatic cancer. Am Fam Phys 89(8):626\u2013632","journal-title":"Am Fam Phys"},{"issue":"4","key":"10074_CR5","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.gassur.2005.09.016","volume":"10","author":"S Hishinuma","year":"2006","unstructured":"Hishinuma S, Ogata Y, Tomikawa M, Ozawa I, Hirabayashi K, Igarashi S (2006) Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings. J Gastrointest Surg 10(4):511\u2013518","journal-title":"J Gastrointest Surg"},{"issue":"19","key":"10074_CR6","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","volume":"364","author":"T Conroy","year":"2011","unstructured":"Conroy T, Desseigne F, Ychou M, Bouch\u00e9 O, Guimbaud R, B\u00e9couarn Y et al (2011) FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 364(19):1817\u20131825","journal-title":"N Engl J Med"},{"issue":"18","key":"10074_CR7","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","volume":"369","author":"DD Von Hoff","year":"2013","unstructured":"Von Hoff DD, Ervin T, Arena FP, Chiorean EG, Infante J, Moore M et al (2013) Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med 369(18):1691\u20131703","journal-title":"N Engl J Med"},{"key":"10074_CR8","volume-title":"New therapeutic strategies in lung cancers","author":"DPS De Ruysscher","year":"2015","unstructured":"De Ruysscher DPS, Oligometastases DC (2015). In: Peters S (ed) New therapeutic strategies in lung cancers. Springer, Cham"},{"key":"10074_CR9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/cancers11081095","volume":"11","author":"M Ghidini","year":"2019","unstructured":"Ghidini M, Petrillo A, Salati M, Khakoo S, Varricchio A, Tomasello G et al (2019) Surgery or locoregional approaches for hepatic oligometastatic pancreatic cancer: myth, hope, or reality? Cancers (Basel). 11:8","journal-title":"Cancers (Basel)."},{"issue":"5","key":"10074_CR10","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.pan.2019.05.466","volume":"19","author":"T Sakaguchi","year":"2019","unstructured":"Sakaguchi T, Valente R, Tanaka K, Satoi S, Del Chiaro M (2019) Surgical treatment of metastatic pancreatic ductal adenocarcinoma: a review of current literature. Pancreatology 19(5):672\u2013680","journal-title":"Pancreatology"},{"issue":"2","key":"10074_CR11","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ejso.2016.10.023","volume":"43","author":"T Hackert","year":"2017","unstructured":"Hackert T, Niesen W, Hinz U, Tjaden C, Strobel O, Ulrich A et al (2017) Radical surgery of oligometastatic pancreatic cancer. Eur J Surg Oncol 43(2):358\u2013363","journal-title":"Eur J Surg Oncol"},{"issue":"10","key":"10074_CR12","first-page":"5573","volume":"37","author":"M Yasukawa","year":"2017","unstructured":"Yasukawa M, Kawaguchi T, Kawai N, Tojo T, Taniguchi S (2017) Surgical treatment for pulmonary metastasis of pancreatic ductal adenocarcinoma: study of 12 cases. Anticancer Res 37(10):5573\u20135576","journal-title":"Anticancer Res"},{"issue":"24","key":"10074_CR13","doi-asserted-by":"crossref","first-page":"5608","DOI":"10.1002\/cncr.25356","volume":"116","author":"O Glehen","year":"2010","unstructured":"Glehen O, Gilly FN, Boutitie F, Bereder JM, Quenet F, Sideris L et al (2010) Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients. Cancer 116(24):5608\u20135618","journal-title":"Cancer"},{"issue":"36","key":"10074_CR14","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1200\/JCO.2009.23.9640","volume":"27","author":"TD Yan","year":"2009","unstructured":"Yan TD, Deraco M, Baratti D, Kusamura S, Elias D, Glehen O et al (2009) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol 27(36):6237\u20136242","journal-title":"J Clin Oncol"},{"issue":"1","key":"10074_CR15","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ejso.2010.11.004","volume":"37","author":"M Deraco","year":"2011","unstructured":"Deraco M, Baratti D, Laterza B, Balestra MR, Mingrone E, Macri A et al (2011) Advanced cytoreduction as surgical standard of care and hyperthermic intraperitoneal chemotherapy as promising treatment in epithelial ovarian cancer. Eur J Surg Oncol 37(1):4\u20139","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"10074_CR16","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1200\/JCO.2020.38.4_suppl.390","volume":"38","author":"A Brandl","year":"2020","unstructured":"Brandl A, Yonemura Y, Glehen O, Sugarbaker PH, Rau B (2020) Long-term survival in patients with peritoneal metastasized gastric cancer treated with cytoreductive surgery and HIPEC: a multi-institutional cohort from PSOGI. J Clin Oncol 38(4):390","journal-title":"J Clin Oncol"},{"issue":"2","key":"10074_CR17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jviscsurg.2015.11.010","volume":"153","author":"C Honor\u00e9","year":"2016","unstructured":"Honor\u00e9 C, Go\u00e9r\u00e9 D, Macovei R, Colace L, Benhaim L, Elias D (2016) Peritoneal carcinomatosis from unusual cancer origins: is there a role for hyperthermic intraperitoneal chemotherapy? J Visc Surg 153(2):101\u2013107","journal-title":"J Visc Surg"},{"issue":"1","key":"10074_CR18","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12957-020-01898-5","volume":"18","author":"N Leigh","year":"2020","unstructured":"Leigh N, Solomon D, Pletcher E, Labow DM, Magge DR, Sarpel U et al (2020) Is cytoreductive surgery and hyperthermic intraperitoneal chemotherapy indicated in hepatobiliary malignancies? World J Surg Oncol 18(1):124","journal-title":"World J Surg Oncol"},{"issue":"33","key":"10074_CR19","first-page":"19","volume":"1","author":"AZ Azzam","year":"2020","unstructured":"Azzam AZ, Amin TM (2020) Combined Intraoperative Radiotherapy (IORT) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) with Cytoreduction Surgery (CRS) as a Novel Approach in the Management of Resectable Pancreatic Cancer. Gulf J Oncol 1(33):19\u201326","journal-title":"Gulf J Oncol"},{"issue":"2","key":"10074_CR20","first-page":"482","volume":"23","author":"AA Tentes","year":"2018","unstructured":"Tentes AA, Pallas N, Karamveri C, Kyziridis D, Hristakis C (2018) Cytoreduction and HIPEC for peritoneal carcinomatosis of pancreatic cancer. J Buon 23(2):482\u2013487","journal-title":"J Buon"},{"key":"10074_CR21","doi-asserted-by":"crossref","first-page":"S324","DOI":"10.1016\/j.hpb.2018.06.356","volume":"20","author":"L Schwarz","year":"2018","unstructured":"Schwarz L, Levine EA, Morris D, Spiliotis J, Pocard M, Kianmanesh R et al (2018) CRS with HIPEC for peritoneal carcinomatosis of pancreatic adenocarcinoma. What do we expect? Results of a Multicenter International Study. HPB 20:S324","journal-title":"HPB"},{"issue":"9","key":"10074_CR22","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.gassur.2005.06.016","volume":"9","author":"JM Farma","year":"2005","unstructured":"Farma JM, Pingpank JF, Libutti SK, Bartlett DL, Ohl S, Beresneva T et al (2005) Limited survival in patients with carcinomatosis from foregut malignancies after cytoreduction and continuous hyperthermic peritoneal perfusion. J Gastrointest Surg 9(9):1346\u20131353","journal-title":"J Gastrointest Surg"},{"issue":"8","key":"10074_CR23","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1080\/02656736.2016.1227094","volume":"32","author":"AA Tentes","year":"2016","unstructured":"Tentes AA, Stamou K, Pallas N, Karamveri C, Kyziridis D, Hristakis C (2016) The effect of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) as an adjuvant in patients with resectable pancreatic cancer. Int J Hypertherm 32(8):895\u2013899","journal-title":"Int J Hypertherm"},{"key":"10074_CR24","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/hpb.12184","volume":"16","author":"H Shiomi","year":"2014","unstructured":"Shiomi H, Naka S, Akabori H, Murakami K, Murata S, Yamamoto H et al (2014) Hyperthermic intraoperative intraperitoneal chemotherapy for advanced pancreatic cancer. HPB 16:610","journal-title":"HPB"},{"issue":"2","key":"10074_CR25","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/SLA.0000000000001705","volume":"265","author":"S Satoi","year":"2017","unstructured":"Satoi S, Fujii T, Yanagimoto H, Motoi F, Kurata M, Takahara N et al (2017) Multicenter phase II study of intravenous and intraperitoneal paclitaxel with S-1 for pancreatic ductal adenocarcinoma patients with peritoneal metastasis. Ann Surg 265(2):397\u2013401","journal-title":"Ann Surg"},{"issue":"8","key":"10074_CR26","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.ejso.2016.03.016","volume":"42","author":"Y Yonemura","year":"2016","unstructured":"Yonemura Y, Canbay E, Li Y, Coccolini F, Glehen O, Sugarbaker PH et al (2016) A comprehensive treatment for peritoneal metastases from gastric cancer with curative intent. Eur J Surg Oncol 42(8):1123\u20131131","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"10074_CR27","first-page":"164","volume":"32","author":"PH Sugarbaker","year":"1989","unstructured":"Sugarbaker PH (1989) Surgical treatment of peritoneal carcinomatosis: 1988 Du Pont lecture. Can J Surg 32(3):164\u2013170","journal-title":"Can J Surg"},{"issue":"5","key":"10074_CR28","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1245\/s10434-009-0866-x","volume":"17","author":"TC Chua","year":"2010","unstructured":"Chua TC, Morris DL, Esquivel J (2010) Impact of the peritoneal surface disease severity score on survival in patients with colorectal cancer peritoneal carcinomatosis undergoing complete cytoreduction and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 17(5):1330\u20131336","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10074_CR29","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1245\/s10434-013-3328-4","volume":"21","author":"J Winer","year":"2014","unstructured":"Winer J, Zenati M, Ramalingam L, Jones H, Zureikat A, Holtzman M et al (2014) Impact of aggressive histology and location of primary tumor on the efficacy of surgical therapy for peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol 21(5):1456\u20131462","journal-title":"Ann Surg Oncol"},{"key":"10074_CR30","doi-asserted-by":"crossref","first-page":"978394","DOI":"10.1155\/2013\/978394","volume":"2013","author":"Y Yonemura","year":"2013","unstructured":"Yonemura Y, Canbay E, Ishibashi H (2013) Prognostic factors of peritoneal metastases from colorectal cancer following cytoreductive surgery and perioperative chemotherapy. Sci World J 2013:978394","journal-title":"Sci World J"},{"key":"10074_CR31","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ejca.2019.10.034","volume":"127","author":"RC Auer","year":"2020","unstructured":"Auer RC, Sivajohanathan D, Biagi J, Conner J, Kennedy E, May T (2020) Indications for hyperthermic intraperitoneal chemotherapy with cytoreductive surgery: a systematic review. Eur J Cancer 127:76\u201395","journal-title":"Eur J Cancer"},{"issue":"5","key":"10074_CR32","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1080\/02656736.2017.1301576","volume":"33","author":"D Go\u00e9r\u00e9","year":"2017","unstructured":"Go\u00e9r\u00e9 D, Passot G, Gelli M, Levine EA, Bartlett DL, Sugarbaker PH et al (2017) Complete cytoreductive surgery plus HIPEC for peritoneal metastases from unusual cancer sites of origin: results from a worldwide analysis issue of the Peritoneal Surface Oncology Group International (PSOGI). Int J Hyperth 33(5):520\u2013527","journal-title":"Int J Hyperth"},{"issue":"1","key":"10074_CR33","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/MPA.0b013e31825abf8c","volume":"42","author":"I Thomassen","year":"2013","unstructured":"Thomassen I, Lemmens VE, Nienhuijs SW, Luyer MD, Klaver YL, de Hingh IH (2013) Incidence, prognosis, and possible treatment strategies of peritoneal carcinomatosis of pancreatic origin: a population-based study. Pancreas 42(1):72\u201375","journal-title":"Pancreas"},{"issue":"3","key":"10074_CR34","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/MPA.0000000000000290","volume":"44","author":"N Takahara","year":"2015","unstructured":"Takahara N, Isayama H, Nakai Y, Sasaki T, Saito K, Hamada T et al (2015) Pancreatic cancer with malignant ascites: clinical features and outcomes. Pancreas 44(3):380\u2013385","journal-title":"Pancreas"},{"issue":"7","key":"10074_CR35","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1097\/MPA.0000000000000163","volume":"43","author":"JH Jo","year":"2014","unstructured":"Jo JH, Chung MJ, Park JY, Bang S, Park SW, Chung JB et al (2014) Clinical characteristics of long-term survivors of inoperable pancreatic cancer: an 8-year cohort analysis in Korea. Pancreas 43(7):1022\u20131031","journal-title":"Pancreas"},{"issue":"5","key":"10074_CR36","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.amjsurg.2010.01.021","volume":"199","author":"CJ Clark","year":"2010","unstructured":"Clark CJ, Traverso LW (2010) Positive peritoneal lavage cytology is a predictor of worse survival in locally advanced pancreatic cancer. Am J Surg 199(5):657\u2013662","journal-title":"Am J Surg"},{"issue":"1","key":"10074_CR37","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1245\/s10434-006-9185-7","volume":"14","author":"J Esquivel","year":"2007","unstructured":"Esquivel J, Sticca R, Sugarbaker P, Levine E, Yan TD, Alexander R et al (2007) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement Society of Surgical Oncology. Ann Surg Oncol 14(1):128\u2013133","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10074_CR38","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.suronc.2009.01.002","volume":"19","author":"M Tewari","year":"2010","unstructured":"Tewari M, Hazrah P, Kumar V, Shukla HS (2010) Options of restorative pancreaticoenteric anastomosis following pancreaticoduodenectomy: a review. Surg Oncol 19(1):17\u201326","journal-title":"Surg Oncol"},{"issue":"2","key":"10074_CR39","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.3747\/co.22.2058","volume":"22","author":"P Dub\u00e9","year":"2015","unstructured":"Dub\u00e9 P, Sideris L, Law C, Mack L, Haase E, Giacomantonio C et al (2015) Guidelines on the use of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal surface malignancy arising from colorectal or appendiceal neoplasms. Curr Oncol 22(2):e100\u2013e112","journal-title":"Curr Oncol"},{"issue":"5","key":"10074_CR40","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1245\/s10434-014-4186-4","volume":"22","author":"S Downs-Canner","year":"2015","unstructured":"Downs-Canner S, Ding Y, Magge DR, Jones H, Ramalingam L, Zureikat A et al (2015) A comparative analysis of postoperative pancreatic fistulas after surgery with and without hyperthermic intraperitoneal chemoperfusion. Ann Surg Oncol 22(5):1651\u20131657","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10074_CR41","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1245\/s10434-014-3976-z","volume":"22","author":"AN Doud","year":"2015","unstructured":"Doud AN, Randle RW, Clark CJ, Levine EA, Swett KR, Shen P et al (2015) Impact of distal pancreatectomy on outcomes of peritoneal surface disease treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 22(5):1645\u20131650","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10074_CR42","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/SLA.0000000000001225","volume":"263","author":"L Schwarz","year":"2016","unstructured":"Schwarz L, Votanopoulos K, Morris D, Yonemura Y, Deraco M, Piso P et al (2016) Is the combination of distal pancreatectomy and cytoreductive surgery with HIPEC reasonable? Results of an international multicenter study. Ann Surg 263(2):369\u2013375","journal-title":"Ann Surg"},{"issue":"10242","key":"10074_CR43","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","volume":"395","author":"JD Mizrahi","year":"2020","unstructured":"Mizrahi JD, Surana R, Valle JW, Shroff RT (2020) Pancreatic cancer. Lancet 395(10242):2008\u20132020","journal-title":"Lancet"},{"issue":"3","key":"10074_CR44","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1001\/jama.297.3.267","volume":"297","author":"H Oettle","year":"2007","unstructured":"Oettle H, Post S, Neuhaus P, Gellert K, Langrehr J, Ridwelski K et al (2007) Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 297(3):267\u2013277","journal-title":"JAMA"},{"issue":"10","key":"10074_CR45","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/jama.2010.1275","volume":"304","author":"JP Neoptolemos","year":"2010","unstructured":"Neoptolemos JP, Stocken DD, Bassi C, Ghaneh P, Cunningham D, Goldstein D et al (2010) Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial. JAMA 304(10):1073\u20131081","journal-title":"JAMA"},{"issue":"9","key":"10074_CR46","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S1470-2045(20)30322-3","volume":"21","author":"D Go\u00e9r\u00e9","year":"2020","unstructured":"Go\u00e9r\u00e9 D, Glehen O, Quenet F, Guilloit JM, Bereder JM, Lorimier G et al (2020) Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP-PRODIGE 15): a randomised, phase 3 study. Lancet Oncol 21(9):1147\u20131154","journal-title":"Lancet Oncol"},{"issue":"10","key":"10074_CR47","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S2468-1253(19)30239-0","volume":"4","author":"CEL Klaver","year":"2019","unstructured":"Klaver CEL, Wisselink DD, Punt CJA, Snaebjornsson P, Crezee J, Aalbers AGJ et al (2019) Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial. Lancet Gastroenterol Hepatol 4(10):761\u2013770","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"10074_CR48","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.suronc.2017.01.002","volume":"26","author":"PH Sugarbaker","year":"2017","unstructured":"Sugarbaker PH (2017) Strategies to improve local control of resected pancreas adenocarcinoma. Surg Oncol 26(1):63\u201370","journal-title":"Surg Oncol"},{"issue":"1","key":"10074_CR49","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/jso.10000","volume":"79","author":"K Ridwelski","year":"2002","unstructured":"Ridwelski K, Meyer F, Hribaschek A, Kasper U, Lippert H (2002) Intraoperative and early postoperative chemotherapy into the abdominal cavity using gemcitabine may prevent postoperative occurence of peritoneal carcinomatosis. J Surg Oncol 79(1):10\u201316","journal-title":"J Surg Oncol"},{"issue":"2","key":"10074_CR50","doi-asserted-by":"crossref","first-page":"174","DOI":"10.2174\/157489209788452876","volume":"4","author":"A Kamath","year":"2009","unstructured":"Kamath A, Yoo D, Stuart OA, Bijelic L, Sugarbaker PH (2009) Rationale for an intraperitoneal gemcitabine chemotherapy treatment for patients with resected pancreatic cancer. Recent Pat Anticancer Drug Discov 4(2):174\u2013179","journal-title":"Recent Pat Anticancer Drug Discov"},{"key":"10074_CR51","unstructured":"Garc\u00eda Santos EP, Padilla Valverde D, Villarejo Campos P, S\u00e1nchez Garc\u00eda S, Mart\u00edn Fern\u00e1ndez J (2018) HIPEC with gemcitabine as an adjuvant locoregional treatment after radical surgery in pancreatic cancer. Presentation of the clinical trial N-2016-004298-41. Pleura and Peritoneum. 3:sA206."},{"issue":"6","key":"10074_CR52","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1245\/s10434-020-08320-0","volume":"27","author":"The Chicago Consensus on Peritoneal Surface Malignancies","year":"2020","unstructured":"The Chicago Consensus on Peritoneal Surface Malignancies (2020) Management of Gastric Metastases. Ann Surg Oncol 27(6):1768\u20131773","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10074_CR53","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1245\/s10434-019-07450-4","volume":"26","author":"I Manzanedo","year":"2019","unstructured":"Manzanedo I, Pereira F, Rihuete Caro C, P\u00e9rez-Viejo E, Serrano \u00c1, Guti\u00e9rrez Calvo A et al (2019) Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer with Peritoneal Carcinomatosis: Multicenter Study of Spanish Group of Peritoneal Oncologic Surgery (GECOP). Ann Surg Oncol 26(8):2615\u20132621","journal-title":"Ann Surg Oncol"}],"container-title":["Clinical & Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-021-10074-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10585-021-10074-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-021-10074-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T09:09:56Z","timestamp":1616490596000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10585-021-10074-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,24]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10074"],"URL":"https:\/\/doi.org\/10.1007\/s10585-021-10074-2","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,24]]},"assertion":[{"value":"12 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}